11 May 2015

Dihydrocodeine Tablets (Dihydrocodeine Tartrate) - United Kingdom

ATC: N02AA
NERVOUS SYSTEM
ANALGESICS
OPIOIDS
NATURAL OPIUM ALKALOIDS
Dihydrocodeine Tablets BP

Generic Matches for Dihydrocodeine Tartrate (2)
Dihydrocodeine Tablets BP 30mg
DHC Continus prolonged release tablets 60mg, 90mg and 120 mg

Last Updated on 11 May 2015 by EPG Health Media Staff

Suggest content to an epgonline.org editor - or let us know about a mistake you have spotted on this page

Dihydrocodeine Tablets BP Indication

As an analgesic for the relief of moderate to severe pain. Dihydrocodeine Tablets 30mg are indicated in all painful conditions where an alert patient is desired, eg sciatica, osteo-arthritis, chronic rheumatoid arthritis, arthritis of the spine, peripheral vascular disease, post-herpetic neuralgia, Paget's disease, malignant disease, post-operative pain.

Because dihydrocodeine, in the recommended doses, causes little or no respiratory depression, its use in the treatment of post-operative pain may reduce the risk of chest complications.

 

Dihydrocodeine Tablets BP Generic Name

Dihydrocodeine Tartrate

Type

POM

Summary Product Characteristics (SPCs) Links
SPC - Dihydrocodeine Tablets BP 30mg (external site)

Related Learning Zones

Prostate Cancer Learning Hub

Prostate Cancer Learning Hub

The Prostate Cancer Learning Hub has been designed with the busy healthcare professional in mind. The resource conveniently organises a range of up-to-date education content, reference materials and decision support tools, all focussing on prostate cancer. The disease awareness section provides you with access to a Prostate Cancer Knowledge Centre, which has been developed to provide you with easy to digest best practice guidance for the treatment and management of patients with prostate cancer.

Type 1 Childhood Diabetes CME

Type 1 Childhood Diabetes CME

In this EACCME-accredited online CME activity Individual Patient Management in Type 1 Childhood Diabetes, healthcare professionals will learn how to assess the psychosocial wellbeing of young patients with type 1 diabetes. 

Upon successful completion of this activity, healthcare professionals (such as endocrinologists, paediatricians, paediatric endocrinologists, diabetes specialists, specialist nurses, primary care physicians) will be awarded 1 European CME credit (ECMEC).

Dihydrocodeine Tablets Marketing Information

Dihydrocodeine Tablets Generic Name
Dihydrocodeine Tartrate
Marketing Company
Actavis UK Limited
Drug Type
POM
Date of Issue, Marketing Authority 01/10/1986

Related Drugs - Pain Management

Back to top